Can Trial Pricing work in Logistics & Supply Chain Technology with operational risk?
Logistics software gets purchased after a costly failure, so a trial should resolve an actual shipment, inventory or hiring workflow rather than show a feature list. Veeqo gives sellers free core shipping functionality and sells additional inventory capability; Tenstreet uses tailored enterprise pricing based on fleet and recruiting scope. Neither proves a fixed-duration Trial Pricing offer here. A warehouse that connects one channel may still suffer overselling elsewhere; a carrier cannot assess driver compliance from a fabricated application.
See how top HealthTech companies found a payer and built recurring revenue, in Business Core.
✓ Skip the success story. Get the decisions behind it ✓ Not a case study. A teardown you can copy from.
Business Core breaks down top HealthTech companies' revenue models, pricing, buyers and revenue risks, so you can see who pays, how they buy and where revenue is exposed.
40 Foundational Decisions
34 Model Frameworks
80 Strategy Patterns
4 Pillars of any Business
Backed by evidence
On which a company is built on
Of proven growth & expansion
Model · Market · Money · Motion
✓ Find relevant precedents in under 2 minutes ✓ Updated every 6 months ✓ 6 ARR stages, from pre-$1M to $100M+
Pick a decision or a strategy.
Go deep on companies that made it
Your exact comparables, one filter away.
The companies you study didn't build by instinct alone.
Neither should you.
Stop studying companies that never faced your call.
Famous case studies won’t fit your decision. These will.
With a Situation or Strategy you need insight on
Open results to see exactly how they did it - and how you can do the same.
The framework walks you through every layer of how the company was built, grown & sustained big
Airwallex
Scrivener / Literature & Latte
Auth0
SocialPilot
Box
Twilio
Revolution Brewing
MeetingPlay
Cuvva
Fivetran
Zoho
Intercom
Thriver
✓ Get the Full list of companies under each ✓ Unlock in-depth intel on each company
From “what should we do?” to a written plan in one sitting
DISTRIBUTION MODEL
Why is it harder to find a reliable payer for recurring revenue in HealthTech?
Because healthcare splits the user, the payer and the decision-maker. Clinicians use the product, insurers or health systems pay, pharmaceutical brands buy attention and patients often pay nothing. Regulation on privacy, advertising and clinical AI adds constraints. A predictable model starts by naming one payer who feels the pain and has a budget. I'd write down, in one line, who signs the cheque and who feels the pain, and be suspicious if they're different people with no budget link.
How do HealthTech companies decide who pays for the product?
• Ask who has a budget line for the problem. Doximity found it in pharmaceutical marketing and health-system hiring, not in clinicians.
• Charge the practitioner when the product replaces their own admin work, as SimplePractice does with a per-clinician price.
• Keep the free side free if the free side creates the value. Doximity keeps clinician-side tools free to maintain engagement and trust.
• Scale price by the number of clinicians and feature depth, so a growing practice pays more without renegotiating.
• Write down what happens if the payer's budget is cut, so you know which customers are exposed.
• Map the money flow on one page: who uses, who approves, who pays and who is affected, and sell to the person who pays.
Which HealthTech companies priced by clinician, by audience or by contract?
These are same-industry precedents, not exact matches.
• SimplePractice: Starter at $49 a month, Essential at $79 and Plus at $99 for the first clinician, with additional practitioners at $37 to $74 a month and claims beyond limits at $0.25 to $0.50 each.
• Doximity: quote-based enterprise pricing for Marketing, Hiring and Workflow Solutions based on audience access, campaign scope and product usage.
• ADP (HR precedent): RUN payroll for businesses under 50 employees, with market references of about $59 to $79 a month plus per-employee fees, and quote-based Workforce Now.
• The unit in each case is something the payer already counts: clinicians, audience reach or employees.
What did Doximity and SimplePractice show to prove their HealthTech revenue was recurring?
Doximity reported subscription revenue of $543.8 million in FY2025 and 119% net revenue retention in Q4 FY2025. SimplePractice shows a per-clinician subscription structure but doesn't disclose ARR. As a cross-industry precedent, Oracle reported that cloud services and licence support produced $44.0 billion, 76.7% of its FY2025 revenue. Retention and recurring share are the two numbers that travel.
What numbers should a HealthTech founder show to prove recurring revenue?
• Shipments completed with correct inventory deduction.
• Verification time for a qualified driver application.
• Use a contained operational lane: one channel-to-shipment flow or one verified driver application, with a rollback path and signed success criteria.
What revenue and retention figures did Doximity, ADP and Oracle publish as HealthTech precedents?
Two are from other industries and are marked as such.
• Doximity (HealthTech): subscription revenue of $543.8 million in FY2025 and net revenue retention of 119% in Q4 FY2025.
• ADP (HR precedent): FY2025 revenue of $20.6 billion, Employer Services retention of 92.1% and no client above 2% of revenue.
• Oracle (HR precedent): FY2025 total revenue of $57.4 billion, with 76.7% from cloud services and licence support.
Free for clinicians or paid by clinicians: which HealthTech payer model did each company choose?
Doximity made the clinician side free and sold access to the audience. SimplePractice made the clinician the payer. Both give recurring revenue, but they carry different risks: concentration in a few pharmaceutical buyers on one side, and commoditisation and small-practice churn on the other. I'd choose the clinician as payer if your product removes work they feel weekly, and the audience model only if you already have a trusted, active professional network.
Should a HealthTech startup monetise the audience or the practitioner?
• Monetise the audience if you have scale and trust.
• Monetise the practitioner if the product removes admin work they feel every week.
• Avoid monetising too early if member trust isn't established.